NYSE:FNA
Paragon 28, Inc.
- Stock
industry
Medical Devicesexchange
New York Stock Exchangewebsite
www.paragon28.comipo date
Jul 14, 2014full time employees
463currency
USD
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating sys...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- Albert DaCosta
- Frank Bono
investors
Partners | Funding Round | Investor Name | Lead Investor |
---|---|---|---|
— | Post-IPO Debt - Paragon 28 | Ares Capital Corporation | Yes |
Tom Schnettler | Series B - Paragon 28 | Piper Jaffray Merchant Banking | Yes |
Kevin Cheng | Series B - Paragon 28 | MVM Life Science Partners | Yes |
acquisitions
Price | Acquiree Name | Announced Date | Transaction Name |
---|---|---|---|
€18M | Disior | 12-01-2022 | Disior acquired by Paragon 28 |
— | Additive Orthopaedics | 01-06-2021 | Additive Orthopaedics acquired by Paragon 28 |
num employees
- 501-1000
funding rounds
Money Raised | Announced Date | Lead Investors | Transaction Name | Number of Investors |
---|---|---|---|---|
$150M | 07-11-2023 | Ares Capital Corporation | Post-IPO Debt - Paragon 28 | 1 |
$73.3M | 25-01-2023 | — | Post-IPO Equity - Paragon 28 | — |
— | 14-08-2020 | MVM Life Science Partners, Piper Jaffray Merchant Banking | Series B - Paragon 28 | 2 |
$200K | 21-11-2011 | — | Debt Financing - Paragon 28 | — |